📰 ET Markets 🔴 BEARISH 🕒 05 Nov 2026, 08:08 PM IST

Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 cr

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 cr

📊

Market & Financial Impact: Glenmark Pharmaceuticals experienced a 56.78 percent drop in consolidated profit after tax during the September quarter. Total revenue from operations decreased to Rs 4,247.32 crore compared to the previous year. The company's total expenses also decreased during the same period, indicating some operational efficiency. A subsidiary of Glenmark Pharma entered into a settlement for USD 15 million with Humana Inc.

💡

Actionable Insight: 🔴 Bearish Risk: Regulatory scrutiny, profit decline, or sell-off risk may create near-term volatility.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Some elections matter more than you know: No crop changed in the fields, yet sugar, coffee and soya got cheaper in a day

You can buy a walkie-talkie online. But can you legally use it?

KYB and KYC: Quick commerce, the Damani premium and what DMart must deliver – 3rd and concluding part

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 cr

🔥 More Live Market Stories

[BELLACASA] Press Release - Bella Casa Fashion & Retail Limited

[HCG] Investor Presentation - Healthcare Global Enterprises Limited

[NBCC] Investor Presentation - NBCC (India) Limited

[TECHM] Analysts/Institutional Investor Meet/Con. Call Updates - Tech Mahindra Limited

[UGROCAP] General Updates - Ugro Capital Limited

[WABAG] Investor Presentation - VA Tech Wabag Limited